Chat Sports
Seahawks news

The Seattle Times · May 6, 2015

Alexion Pharma to pay $8.4B for Synageva BioPharma

FILE – In this Nov. 3, 2011 file photo, Sanj Patel, President and CEO of Synageva BioPharma Corp., attends the opening bell ceremony at Nasdaq in New York. Alexion...Alexion Pharmaceuticals will buy Synageva BioPharma in an $8.4 billion deal for a rare disease-treatment maker that lost nearly $60 million in the first quarter and has no products on the market.

Alexion Pharmaceuticals will pay a huge premium to buy Synageva BioPharma in an $8.4 billion deal for a rare disease treatment maker that lost nearly $60 million in the first quarter and has no products on the market.

Full story at The Seattle Times

From Chat Sports

Seahawks Today · Watch + Read · 8h Seahawks News: Seattle Receives Triple Dose of Major Updates

Chat Sports show

Seahawks Today

with Will Ortner

Subscribe

More Seahawks news

Seahawks fan chat: Chargers vs. Ravens on Monday Night Football, I guess Field Gulls · 7h Improvements In Run Game, Special Teams Play & More From Mike Macdonald's Monday Press Conference Seahawks Official Site · 8h Seahawks create open roster spot ahead of bye week Field Gulls · 8h Raiders' Klint Kubiak got firsthand reminder of Seahawks' defensive nightmare Fansided · 8h Seahawks Bye Week Entertainment Seahawks Official Site · 9h How Seahawks should handle Sam Darnold, Drew Lock question | Analysis The Seattle Times · 9h All Seahawks news